Sophia (Sujin) Kim 4/28/25 Sophia (Sujin) Kim 4/28/25

Orum Therapeutics Provides Program Update and Announces Drug Candidate Nomination

Sophia (Sujin) Kim 4/21/25 Sophia (Sujin) Kim 4/21/25

Orum Therapeutics Appoints Dr. Sang Hyun Lee as Vice President, Research Site Head, Korea, to Accelerate Innovation in Novel Degrader-Antibody Conjugates

Sophia (Sujin) Kim 2/3/25 Sophia (Sujin) Kim 2/3/25

Orum Therapeutics Announces Pricing of Initial Public Offering

Sophia (Sujin) Kim 1/24/25 Sophia (Sujin) Kim 1/24/25

Notice of New Share Issuance for KOSDAQ Listing

Sophia (Sujin) Kim 11/29/24 Sophia (Sujin) Kim 11/29/24

Orum Therapeutics to Relaunch Initial Public Offering Next Year